TDOC Teladoc Health, Inc.
Teladoc Health, Inc. (TDOC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 14% planned / 86% discretionary
Largest single sale: $256.6K.
Where they traded
Last open-market purchase: November 14, 2025 , by Paulus Kenneth H .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sell | 17,805 | $6.10 | $108.7K | 465,535 −3.7% of holding | |
| Bliss Kelly | President, U.S. Group Health | Sell 10b5-1 | 2,500 | $9.50 | $23.8K | 84,878 −2.9% of holding | |
| Catapano Joseph Ronald | Chief Accounting Officer | Sell | 653 | $9.10 | $5.9K | 12,267 −5.1% of holding | |
| Bliss Kelly | President, U.S. Group Health | Sell 10b5-1 | 2,500 | $9.00 | $22.5K | 87,378 −2.8% of holding | |
| Bliss Kelly | President, U.S. Group Health | Sell 10b5-1 | 2,500 | $8.50 | $21.3K | 89,878 −2.7% of holding | |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sell | 18,074 | $6.94 | $125.5K | 414,622 −4.2% of holding | |
| Rodrigues Fernando M. | President of BetterHelp | Sell 10b5-1 | 9,572 | $7.40 | $70.8K | None left | |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sell | 19,132 | $7.63 | $145.9K | 389,894 −4.7% of holding | |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | Sell | 7,906 | $7.63 | $60.3K | 110,261 −6.7% of holding | |
| Bliss Kelly | President, U.S. Group Health | Sell | 7,679 | $7.63 | $58.6K | 92,378 −7.7% of holding | |
| Nueno Carlos | President, International | Sell | 6,196 | $7.63 | $47.3K | 57,671 −9.7% of holding | |
| Rodrigues Fernando M. | President of BetterHelp | Sell | 5,677 | $7.63 | $43.3K | 9,572 −37.2% of holding | |
| Catapano Joseph Ronald | Chief Accounting Officer | Sell | 284 | $7.63 | $2.2K | 10,837 −2.6% of holding | |
| Catapano Joseph Ronald | Chief Accounting Officer | Sell | 675 | $5.11 | $3.5K | 10,249 −6.2% of holding | |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sell | 27,731 | $5.49 | $152.2K | 364,784 −7.1% of holding | |
| Rodrigues Fernando M. | President of BetterHelp | Sell 10b5-1 | 25,086 | $4.98 | $125.0K | None left | |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sell | 50,145 | $5.12 | $256.6K | 327,862 −13.3% of holding | |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | Sell | 27,083 | $5.12 | $138.6K | 103,239 −20.8% of holding | |
| Bliss Kelly | President, U.S. Group Health | Sell | 26,647 | $5.12 | $136.4K | 84,747 −23.9% of holding | |
| Nueno Carlos | President, International | Sell | 20,165 | $5.12 | $103.2K | 50,595 −28.5% of holding | |
| Rodrigues Fernando M. | President of BetterHelp | Sell | 16,314 | $5.12 | $83.5K | 25,086 −39.4% of holding | |
| Catapano Joseph Ronald | Chief Accounting Officer | Sell | 1,333 | $5.12 | $6.8K | 8,841 −13.1% of holding | |
| Catapano Joseph Ronald | Chief Accounting Officer | Sell | 758 | $7.14 | $5.4K | 6,686 −10.2% of holding | |
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER | Sell | 17,138 | $7.63 | $130.8K | 201,036 −7.9% of holding | |
| Rodrigues Fernando M. | President of BetterHelp | Sell 10b5-1 | 4,209 | $7.48 | $31.5K | None left | |
| Vandervoort Adam C | CHIEF LEGAL OFFICER, SECRETARY | Sell | 5,720 | $7.49 | $42.8K | 80,732 −6.6% of holding | |
| Bliss Kelly | President, U.S. Group Health | Sell | 4,582 | $7.49 | $34.3K | 60,054 −7.1% of holding | |
| Nueno Carlos | President, International | Sell | 3,897 | $7.49 | $29.2K | 27,175 −12.5% of holding | |
| Rodrigues Fernando M. | President of BetterHelp | Sell | 2,324 | $7.49 | $17.4K | 4,209 −35.6% of holding | |
| Paulus Kenneth H | Director | Buy 10b5-1 | 10,000 | $6.94 | $69.4K | 10,000 | |
| Catapano Joseph Ronald | Chief Accounting Officer | Sell | 2,972 | $7.88 | $23.4K | 5,361 −35.7% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.